US Patent Issued to AMPHASTAR NANJING PHARMACEUTICALS on June 10 for "Pro-insulin aspart structure and method for preparing insulin aspart" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,732, issued on June 10, was assigned to AMPHASTAR NANJING PHARMACEUTICALS INC (Jiangsu, China).

"Pro-insulin aspart structure and method for preparing insulin aspart" was invented by Chuangen Tang (Jiangsu, China), Shangshu Pan (Jiangsu, China), Xiaorui Liu (Jiangsu, China), Cheng Li (Jiangsu, China), Huaiyan Cui (Jiangsu, China), Song Chen (Jiangsu, China), Haoning Zhang (Jiangsu, China) and Jeffrey Ding (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a novel pro-insulin aspart structure design and a method for preparing the pro-insulin aspart. The method comprises designing the pro-insulin aspart sequence, constructing ...